Cyclosporine-A, but not tacrolimus significantly increases reactivity of vascular smooth muscle cells

Pharmacological Reports

Volumn 68, Issue 1, 2016, Pages 201-205

  Grzes̈k, Elzbieta ^a   Malinowski, Bartosz ^a   Wiciński, Michał ^a   Szadujkis Szadurska, Katarzyna ^a   Sinjab, Thabit A ^a   Manysiak, Sławomir ^a   Tejza, Barbara ^a   Słupski, MacIej ^a   Odrowąz Sypniewska, Grazyna ^a   Grzes̈k, Grzegorz ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Cyclosporine A; Hypertension; Smooth muscle reactivity; Tacrolimus

Indexed keywords

CALCIUM ION; CYCLOSPORIN A; TACROLIMUS; CALCIUM; CYCLOSPORIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY MUSCLE; ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENDOPLASMIC RETICULUM; EXTRACELLULAR CALCIUM; EXTRACELLULAR SPACE; FLOW RATE; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; MALE; NONHUMAN; PERFUSION PRESSURE; RAT; SMOOTH MUSCLE CONTRACTILITY; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; WISTAR RAT;

ANIMALS; CALCIUM; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTENSION; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RATS; RATS, WISTAR; TACROLIMUS; VASOCONSTRICTION;

EID: 84946712687     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2015.08.012     Document Type: Article

References (29)

1. M.E. Paulen, S.G. Folger, K.M. Curtis, and D.J. Jamieson Contraceptive use among solid organ transplant patients: a systematic review Contraception 82 1 2010 102 112
2. D. Pritchard Sourcing a chemical succession for cyclosporin from parasites and human pathogens Drug Discovery Today 10 10 2005 688 691
3. C. Brandt, P. Liman, H. Bendfeldt, K. Mueller, P. Reinke, A. Radbruch, and et al. Whole blood flow cytometric measurement of NFATc1 and IL-2 expression to analyze cyclosporine A-mediated effects in T cells Cytometry A 77 7 2010 607 613
4. M.W. Ho, B. Deng, S. Benoit, J. Chen, D. Wang, D. Boschelli, and et al. Comparison of dexamethasone and cyclosporine to selective protein kinase C-theta inhibitor effects on blood IL-2 production and T cell activation J Immunol 182 2009 35.32
5. N.A. Salem, E.A. Salem, A.M. Maarouf, M. Kamel, H. Elgalaly, M. Radwan, and et al. Protective effect of trapidil and l-arginine against renal and hepatic toxicity induced by cyclosporine in rats Ren Fail 32 8 2010 959 968
6. W. Xue, Q. Zhang, Y. Xu, W. Wang, X. Zhang, and X. Hu Effects of tacrolimus and cyclosporine treatment on metabolic syndrome and cardiovascular risk factors after renal transplantation: a meta-analysis Chin Med J 127 12 2014 2376 2381
7. A. Carmona, M. Díaz-Ricart, M. Palomo, P. Molina, M. Pino, M. Rovira, and et al. Distinct deleterious effects of cyclosporine and tacrolimus and combined tacrolimus-sirolimus on endothelial cells: protective effect of defibrotide Biol Blood Marrow Transplant 19 10 2013 1439 1445
8. W.A. Large, S.N. Saleh, and A.P. Albert Role of phosphoinositol 4,5-bisphosphate and diacylglycerol in regulating native TRPC channel proteins in vascular smooth muscle Cell Calcium 45 6 2009 574 582
9. 2+ exchanger knockout mice Am J Physiol Heart Circ Physiol 298 5 2010 1484 1491
10. A.M. Misior, D.A. Deshpande, M.J. Loza, R.M. Pascual, J.D. Hipp, and R.B. Penn Glucocorticoid and protein kinase A-dependent transcriptome regulation in airway smooth muscle Am J Respir Cell Mol Biol 41 1 2009 24 39
11. R.D. Rainbow, R.I. Norman, D.E. Everitt, J.L. Brignell, N.W. Davies, and N.B. Standen Endothelin-I and angiotensin II inhibit arterial voltage-gated K+ channels through different protein kinase C isoenzymes Cardiovasc Res 83 3 2009 493 500
12. 2+]I and force in human myometrium Reprod Sci 16 1 2009 71 79
13. V. von Burstin, L. Xiao, and M.A. Kazanietz Bryostatin 1 inhibits phorbol ester-induced apoptosis in prostate cancer cells by differentially modulating protein kinase C (PKC) translocation and preventing PKC-mediated release of tumor necrosis factor-α Mol Pharmacol 78 3 2010 325 332
14. G. Yang, T. Li, J. Xu, and L. Liu PKC plays an important mediated effect in arginine vasopressin induced restoration of vascular responsiveness and calcium sensitization following hemorrhagic shock in rats Eur J Pharmacol 628 1-3 2010 148 154
15. G. Grzes̈k, M. Wiciński, B. Malinowski, E. Grzes̈k, S. Manysiak, G. Odrowąż-Sypniewska, and et al. Calcium blockers inhibits cyclosporine A-induced hyperreactivity of vascular smooth muscle cells Mol Med Rep 5 6 2012 1468 1474
16. G. Grzes̈k, M. Koziński, U. Tantry, M. Wiciński, T. Fabiszak, E.P. Navarese, and et al. High-dose, but not low-dose, aspirin impairs anticontractile effect of ticagrelor following ADP stimulation in rat tail artery smooth muscle cells BioMed Res Int 2013 928271 10.1155/2013/928271 8 pages
17. J. Van Rossum Cumulative dose-response curves. Technique for the making of dose-responses curves in isolated organs and the evaluation of drugs parameters Arch Int Pharmacodyn 143 1963 299 330
18. T. Kenakin Pharmacologic analysis of drug-receptor interaction 1997 Raven Press
19. 1-adrenoceptor function in pretreated with lipopolysaccharides rat tail artery Pol J Pharmacol 53 6 2001 605 613
20. G. Grzes̈k, and L. Szadujkis-Szadurski Physiological antagonism of angiotensin II and lipopolysaccharides in early endotoxemia: pharmacometric analysis Pol J Pharmacol 55 5 2003 753 762
21. S.A. Nasser, A.I. Elmallah, R. Sabra, M.M. Khedr, M.M. El-Din, and M.M. El-Mas Blockade of endothelin ET(A), but not thromboxane, receptors offsets the cyclosporine-evoked hypertension and interrelated baroreflex and vascular dysfunctions Eur J Pharmacol 727 2014 52 59
22. G. Grzes̈k, B. Malinowski, E. Grzes̈k, M. Wiciński, and K. Szadujkis-Szadurska Direct regulation of vascular smooth muscle contraction by mastoparan-7 Biomed Rep 2 1 2014 34 38
23. F. Cottet-Maire, P.V. Avdonin, E. Roulet, T.M. Buetler, N. Mermod, and U.T. Ruegg Upregulation of vasopressin V1A receptor mRNA and protein in vascular smooth muscle cells following cyclosporin A treatment Br J Pharmacol 132 4 2001 909 917
24. G.J. Wang, Y.L. Lin, C.H. Chen, X.C. Wu, J.F. Liao, and J. Ren Cellular calcium regulatory machinery of vasorelaxation elicited by petasin Clin Exp Pharmacol Physiol 37 3 2010 309 315
25. D.H. Shin, H.M. Park, K.A. Jung, H.G. Choi, J.A. Kim, D.D. Kim, and et al. The NRF2-heme oxygenase-1 system modulates cyclosporin A-induced epithelial-mesenchymal transition and renal fibrosis Free Radical Biol Med 48 8 2010 1051 1063
26. Y. Hara, N. Kawagishi, W. Nakanishi, K. Tokodai, C. Nakanishi, S. Miyagi, and et al. Prevalence and risk factors of obesity: hypertension, dyslipidemia and diabetes mellitus before and after adult living donor liver transplantation Hepatol Res 45 7 2015 764 770
27. P. Przybyłowski, J. Małyszko, J.S. Małyszko, G. Kobus, J. Sadowski, and M. Mys̈liwiec Blood pressure control in orthotopic heart transplant and kidney allograft recipients is far from satisfactory Transplant Proc 42 10 2010 4263 4266
28. G. Wasilewski, P. Przybyłowski, L. Janik, E. Nowak, J. Sadowski, and J. Małyszko Inadequate blood pressure control in orthotopic heart transplant: is there a role of kidney function and immunosuppressive regimen? Transplant Proc 46 8 2014 2830 2834
29. H.M. El-Gowelli, and M.M. El-Mas Central modulation of cyclosporine-induced hypertension Naunyn Schmiedebergs Arch Pharmacol 388 3 2015 351 361